EdgarLookup

Neumora Therapeutics, Inc. — EFFECT Filings

2 EFFECT filings on record

This page lists all EFFECT filings submitted to the SEC by Neumora Therapeutics, Inc. (NMRA), sorted by most recent first. Each row links to the full filing on EdgarLookup. Neumora Therapeutics, Inc. has filed 2 EFFECT documents with the SEC since 2021. To view all SEC filings by Neumora Therapeutics, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-Q 144 3 4 424B4 8-A12B 8-K 8-K/A CERT CORRESP D DEF 14A DEFA14A DRS DRS/A DRSLTR EFFECT POS AM POSASR PRE 14A S-1 S-1/A S-3ASR S-8 SC 13D SC 13D/A SC 13G SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
EFFECT — 9999999995-25-000791 Mar 26, 2025 —
EFFECT — 9999999995-23-002676 Sep 14, 2023 —